Page last updated: 2024-09-02

fingolimod hydrochloride and Chemical and Drug Induced Liver Injury, Chronic

fingolimod hydrochloride has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Chang, B; He, X; Kang, K; Pan, D; Sun, Y1
Jin, Z; Sun, M; Weng, H; Ye, H; Yuan, Y1
Adams, DH; Frampton, J; Haldar, D; Henderson, NC; Houlihan, DD; Kalia, N; Kavanagh, D; King, A; Luu, N; Newsome, PN; Owen, A; Penny, J; Ramachandran, P; Reynolds, G; Sumption, H; Suresh, S; Than, NN1

Other Studies

3 other study(ies) available for fingolimod hydrochloride and Chemical and Drug Induced Liver Injury, Chronic

ArticleYear
FTY720 attenuates APAP‑induced liver injury via the JAK2/STAT3 signaling pathway.
    International journal of molecular medicine, 2022, Volume: 49, Issue:5

    Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Fingolimod Hydrochloride; Male; Mice; Mice, Inbred C57BL; Signal Transduction

2022
FTY-720 alleviates diabetes-induced liver injury by inhibiting oxidative stress and inflammation.
    Fundamental & clinical pharmacology, 2023, Volume: 37, Issue:5

    Topics: Animals; Chemical and Drug Induced Liver Injury, Chronic; Diabetes Mellitus, Experimental; Fingolimod Hydrochloride; Glucose; Inflammation; Liver; Mice; NF-kappa B; Oxidative Stress; Toll-Like Receptor 4

2023
Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis.
    Gastroenterology, 2017, Volume: 153, Issue:1

    Topics: Actins; Aldehyde-Lyases; Animals; Cell Line; Cell Movement; Chemical and Drug Induced Liver Injury, Chronic; Collagen Type I; Collagen Type I, alpha 1 Chain; Female; Fingolimod Hydrochloride; Gene Expression; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Liver; Liver Cirrhosis; Lymph; Lysophospholipids; Macrophages; Male; Membrane Proteins; Mice; Monocytes; Neutrophils; Phosphoric Monoester Hydrolases; Phosphotransferases (Alcohol Group Acceptor); Sphingosine

2017